Evidence map›Paper›PMID 35356153›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages.

Yuan Yin, Bingxin Liu, Yulin Cao, Surui Yao, Yuhang Liu, Guoying Jin, Yan Qin, Ying Chen, Kaisa Cui, Leyuan Zhou and 4 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed
20.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 228 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Sulconazole Suppresses Colorectal Cancer Immune Evasion by Inhibiting Glycolysis to Upregulate OVOL2 PARylation and Induce PANoptosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Strategies to target PD-1/PD-L1 in the tumor microenvironment.Cellular oncology (Dordrecht, Netherlands) · 2026
    Review
  17. Review
  18. Review
  19. Article
  20. Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yuan YinWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Bingxin LiuWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Yulin CaoWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Surui YaoWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Yuhang LiuWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Guoying JinWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Yan QinDepartment of Pathology Affiliated Hospital of Jiangnan University Wuxi Jiangsu 214062 China.
Ying ChenWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Kaisa CuiWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Leyuan ZhouDepartment of Radiation Oncology Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Zehua BianWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Bojian FeiDepartment of Gastrointestinal Surgery Affiliated Hospital of Jiangnan University Wuxi 214062 China.
Shenglin HuangFudan University Shanghai Cancer Center and Institutes of Biomedical Sciences Fudan University Shanghai 200032 China.
Zhaohui HuangWuxi Cancer Institute Affiliated Hospital of Jiangnan University Wuxi 214062 China.ORCID 0000-0002-0117-9976
Jiangnan University · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-associated macrophages (TAMs) are one of the most abundant cell types in colorectal cancer (CRC) tumor microenvironment (TME). Recent studies observed complicated "cross-talks" between cancer cells and macrophages in TME. However, the underlying mechanisms are still poorly elucidated. Here, PD-L1 levels are very low in CRC cells but highly abundant in TAMs, and a specific PD-L1

Indexed as

Colorectal NeoplasmsExtracellular VesiclesB7-H1 AntigenCell Line, TumorHumansTumor-Associated MacrophagesTumor EscapeTumor MicroenvironmentB7-H1 AntigenCD274 protein, humancolorectal cancermacrophageMicroRNAPD‐L1small extracellular vesicles

Identifiers

PMID35356153
PMCPMC8948581
OpenAlexW4205564996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.